359 related articles for article (PubMed ID: 12124219)
1. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
[TBL] [Abstract][Full Text] [Related]
2. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development.
Scott NJ; Ellmers LJ; Lainchbury JG; Maeda N; Smithies O; Richards AM; Cameron VA
Biochim Biophys Acta; 2009 Dec; 1792(12):1175-84. PubMed ID: 19782130
[TBL] [Abstract][Full Text] [Related]
3. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis.
Ellmers LJ; Scott NJ; Piuhola J; Maeda N; Smithies O; Frampton CM; Richards AM; Cameron VA
J Mol Endocrinol; 2007 Feb; 38(1-2):245-57. PubMed ID: 17293444
[TBL] [Abstract][Full Text] [Related]
4. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
[TBL] [Abstract][Full Text] [Related]
5. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models.
Pandey KN; Oliver PM; Maeda N; Smithies O
Endocrinology; 1999 Nov; 140(11):5112-9. PubMed ID: 10537139
[TBL] [Abstract][Full Text] [Related]
6. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice.
Sun JZ; Chen SJ; Li G; Chen YF
Am J Physiol Lung Cell Mol Physiol; 2000 Sep; 279(3):L511-9. PubMed ID: 10956626
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Cardiac Natriuretic Peptide Signaling Promotes Peripartum Cardiomyopathy-Like Remodeling in the Mouse Heart.
Otani K; Tokudome T; Kamiya CA; Mao Y; Nishimura H; Hasegawa T; Arai Y; Kaneko M; Shioi G; Ishida J; Fukamizu A; Osaki T; Nagai-Okatani C; Minamino N; Ensho T; Hino J; Murata S; Takegami M; Nishimura K; Kishimoto I; Miyazato M; Harada-Shiba M; Yoshimatsu J; Nakao K; Ikeda T; Kangawa K
Circulation; 2020 Feb; 141(7):571-588. PubMed ID: 31665900
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
10. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Vellaichamy E; Zhao D; Somanna N; Pandey KN
Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078
[TBL] [Abstract][Full Text] [Related]
13. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis.
Takemura G; Takatsu Y; Doyama K; Itoh H; Saito Y; Koshiji M; Ando F; Fujiwara T; Nakao K; Fujiwara H
J Am Coll Cardiol; 1998 Mar; 31(4):754-65. PubMed ID: 9525543
[TBL] [Abstract][Full Text] [Related]
14. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
16. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure.
Sakata Y; Yamamoto K; Masuyama T; Mano T; Nishikawa N; Kuzuya T; Miwa T; Hori M
J Hypertens; 2001 Oct; 19(10):1905-12. PubMed ID: 11593113
[TBL] [Abstract][Full Text] [Related]
17. Valporic acid enhances the Atrial Natriuretic Peptide (ANP) mediated anti-hypertrophic activity by modulating the Npr1 gene transcription in H9c2 cells in vitro.
Manivasagam S; Velusamy T; Sowndharajan B; Chandrasekar N; Dhanusu S; Vellaichamy E
Eur J Pharmacol; 2017 Oct; 813():94-104. PubMed ID: 28743391
[TBL] [Abstract][Full Text] [Related]
18. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice.
Sangaralingham SJ; Tse MY; Pang SC
J Endocrinol; 2007 Jul; 194(1):143-52. PubMed ID: 17592028
[TBL] [Abstract][Full Text] [Related]
19. Chamber-dependent circadian expression of cardiac natriuretic peptides.
Goetze JP; Georg B; Jørgensen HL; Fahrenkrug J
Regul Pept; 2010 Feb; 160(1-3):140-5. PubMed ID: 20035806
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
